Network origin in Florence Rozen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Medical Discovery Management Corp.
Medical Discovery Management Corp. Investment ManagersFinance Medical Discovery Management Corp. (MDMC) is a venture capital fund manager located in Toronto. They are a subsidiary of JovFunds Management, Inc. Their ultimate parent is Jovian Capital Corp. (Toronto: JOV.TO)
9
| Extinct | Investment Managers | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Florence Rozen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Director/Board Member | |
APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
CONSTELLATION SOFTWARE INC. | Packaged Software | Director/Board Member | |
ViOptix, Inc.
ViOptix, Inc. Medical SpecialtiesHealth Technology ViOptix, Inc. develops a tissue oximetry technology for the measurement of local tissue oxygen saturation. It offers T.Ox Tissue Oximeter, a lightweight and portable A/C power-operated unit. The was founded in 2009 and is headquartered in Fremont, CA. | Medical Specialties | Director/Board Member | |
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
Endoceutics, Inc.
Endoceutics, Inc. Pharmaceuticals: MajorHealth Technology EndoCeutics, Inc. develops hormone therapies. It offers products for vulvovaginal atrophy-sexual dysfunction, treatment of hot flushes and loss of bone, breast cancer treatment, treatment of endometriosis, treatment of prostate cancer, and male hypogonadism. The company was founded on July 26, 2006 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Director/Board Member | |
ENDO INTERNATIONAL PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
McGill University | College/University | Doctorate Degree Doctorate Degree | |
York University | College/University | Masters Business Admin | |
Ellipsis Neurotherapeutics, Inc.
Ellipsis Neurotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member | |
University of Alberta | College/University | Corporate Officer/Principal | |
University of Toronto | College/University | Graduate Degree | |
University of Western Ontario | College/University | Corporate Officer/Principal Doctorate Degree | |
PainCeptor Pharma Corp.
PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Pharmaceuticals: Major | Director/Board Member | |
MedInnova Partners, Inc.
MedInnova Partners, Inc. Investment ManagersFinance MedInnova Partners, Inc is a venture capital firm, founded in 2000. The firm headquartered in Halifax, Nova Scotia. | Investment Managers | Chief Executive Officer | |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pasteur Mérieux Connaught | Corporate Officer/Principal | ||
NATRIX Separations, Inc.
NATRIX Separations, Inc. Medical SpecialtiesHealth Technology NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada. | Medical Specialties | Director/Board Member | |
VICAPSYS LIFE SCIENCES, INC. | Pharmaceuticals: Major | Founder | |
DC Bio Corp.
DC Bio Corp. BiotechnologyHealth Technology DC Bio Corp. develops technology for application to cancer and diseases associated with chronic viral infections. The company is headquartered in Halifax, Canada. | Biotechnology | President | |
Mcmaster Innovation Park
Mcmaster Innovation Park Miscellaneous Commercial ServicesCommercial Services Mcmaster Innovation Park operates as a premier research park that offers collaborative space for researchers and entrepreneurs to co-locate, connect and commercialize. The company is headquartered in Hamilton, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Canadian Network for Vaccines & Immunotherapeutics | Director/Board Member | ||
Robarts Research Institute
Robarts Research Institute Miscellaneous Commercial ServicesCommercial Services Robarts Research Institute engages in the provision of medical research facilities for investigating various diseases such as diabetes, heart and stroke, Alzheimer's, and cancer diseases. The company was founded by Henry Barnett in 1986 and is headquartered in London, Canada. | Miscellaneous Commercial Services | President | |
VISTAGEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Investment Managers | Chief Executive Officer | |
Crimson Capital, Inc.
Crimson Capital, Inc. Financial ConglomeratesFinance Crimson Capital, Inc. provides investment services. The joint venture company is based in Albany, NY. The company was founded by Roland Eschle. Linda Boland Abraham has been the CEO of the company since 2014. | Financial Conglomerates | President | |
CellAegis Devices, Inc.
CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology CellAegis Devices, Inc. develops device for the treatment of cardiac patients. . It offers autoRIC Device, an automated noninvasive device that provides point of care delivery of remote ischemic conditioning. The company was founded by John Berton, Andrew N. Redington and Christopher Caldarone and is headquartered in Toronto, Canada. | Electronic Equipment/Instruments | Director/Board Member | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Centurion Asset Management, Inc. | Investment Trusts/Mutual Funds | Director/Board Member | |
OsteoqQC, Inc.
OsteoqQC, Inc. BiotechnologyHealth Technology OsteoqQC, Inc. develops drugs for the treatment of bone-related diseases. The company was founded by Debra Ellies and is headquartered in Montreal, Canada. | Biotechnology | Director/Board Member | |
HLS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Operating Officer | |
VENUS CONCEPT INC. | Medical Specialties | President | |
TOPICUS.COM INC. | Packaged Software | Director/Board Member | |
BAUSCH + LOMB CORPORATION | Medical Specialties | Corporate Officer/Principal | |
Topicus.com BV
Topicus.com BV Packaged SoftwareTechnology Services Part of Topicus.com, Inc., Topicus.com BV provides vertical market software and platforms. The company is based in Deventer, Netherlands. Robin van Poelje has been the CEO of the Dutch company since 2021. | Packaged Software | Director/Board Member | |
Cross-Border Impact Ventures
Cross-Border Impact Ventures Investment ManagersFinance Cross-Border Impact Ventures (Cross-Border Impact Ventures) is a venture capital firm founded in 2019 by Megan Dover. The firm is headquartered in Toronto, Canada. | Investment Managers | Private Equity Investor | |
LITHA HEALTHCARE GROUP LIMITED | Biotechnology | Director/Board Member |
Statistics
International
Canada | 36 |
United States | 12 |
Ireland | 2 |
Vietnam | 2 |
Netherlands | 2 |
Sectoral
Health Technology | 27 |
Finance | 7 |
Consumer Services | 7 |
Technology Services | 5 |
Commercial Services | 5 |
Operational
Director/Board Member | 40 |
Private Equity Investor | 18 |
Corporate Officer/Principal | 13 |
President | 7 |
Private Equity Analyst | 4 |
Most connected contacts
Insiders | |
---|---|
Brian Underdown | 34 |
Donna Parr | 14 |
Mark J. Poznansky | 11 |
Hermanth Varghese | 11 |
Serge Carrière | 3 |
Denis Gagnon | 2 |
Michael Cross | 2 |
Diane Vaselenak | 2 |
Benjamin Matthews | 2 |
- Stock Market
- Insiders
- Florence Rozen
- Company connections